Early identification and management of regulatory risks—covering pathways, claims validation, ingredient screening, clinical evidence, QMS, supplier qualification, approval processes, and…
A structured regulatory intelligence program accelerates compliance decisions by halving decision time, reducing errors, enhancing submissions, and ensuring proactive FDA…
This guide details building a submission-ready compliance plan for US FDA and Health Canada, emphasizing regulatory understanding, gap assessments, tailored…
This checklist guides FDA and Health Canada submissions by ensuring complete documentation, regulatory gap analysis, labeling compliance, quality system readiness,…
Early planning in FDA and Health Canada submissions reduces rework by defining intent, conducting gap assessments, coordinating teams, managing data,…
US and Canada cosmetic compliance demands strict ingredient review, FDA MoCRA registration, bilingual labels in Canada, accurate claims, GMP ISO…
Medical device classification in the US (FDA Class I-III) and Canada (Health Canada Class I-IV) determines risk, regulatory pathways (510(k),…
Entering Canada with natural health products requires obtaining Health Canada's Natural Product Number (NPN) and Site Licence (SL), ensuring GMP…
Build a compliance-ready QMS by aligning FDA QMSR and ISO 13485 standards using a risk-based approach, a 90-day roadmap, and…
This guide identifies 12 causes of FDA and Health Canada submission delays—like incomplete data and poor eCTD discipline—and offers tactics…
Call Now Button